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Existing chronic kidney disease (CKD) is among the most
potent predictors of postoperative acute kidney injury (AKI).
Here we quantified this risk in a multicenter, observational
study of 9425 patients who survived to hospital discharge
after major surgery. CKD was defined as a baseline estimated
glomerular filtration rate o45ml/min per 1.73m2. AKI was
stratified according to the maximum simplified RIFLE
classification at hospitalization and unresolved AKI defined as
a persistent increase in serum creatinine of more than half
above the baseline or the need for dialysis at discharge. A
Cox proportional hazard model showed that patients with
AKI-on-CKD during hospitalization had significantly worse
long-term survival over a median follow-up of 4.8 years
(hazard ratio, 3.3) than patients with AKI but without CKD.
The incidence of long-term dialysis was 22.4 and 0.17 per 100
person-years among patients with and without existing CKD,
respectively. The adjusted hazard ratio for long-term dialysis
in patients with AKI-on-CKD was 19.8 compared to patients
who developed AKI without existing CKD. Furthermore, AKI-
on-CKD but without kidney recovery at discharge had a
worse outcome (hazard ratios of 4.6 and 213, respectively) for
mortality and long-term dialysis as compared to patients
without CKD or AKI. Thus, in a large cohort of postoperative
patients who developed AKI, those with existing CKD were at
higher risk for long-term mortality and dialysis after hospital
discharge than those without. These outcomes were
significantly worse in those with unresolved AKI at discharge.
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Acute kidney injury (AKI) is a serious complication of
surgery, resulting in a prolonged hospital stay and high
mortality.1 AKI develops in 5–60% of postoperative patients
and is associated with hospital mortality rates of 60–90%.2–4
Recently, the adverse effects of AKI on long-term patient
outcomes were further confirmed in many studies.5,6
Although the risk of death, cardiovascular events, and
hospitalization rises sharply in patients with an estimated
glomerular filtration rate (eGFR) o45 ml/min per 1.73 m2
(ref. 7), the long-term effect after acute-on-chronic kidney
disease (CKD–AKI) in the critical setting5,6,8 is poorly
studied. Globally, the increasing incidence and prevalence
of chronic kidney disease (CKD) is associated with adverse
health outcomes and high health-care costs. Existing CKD
appears to be among the most potent predictors of AKI
following major surgery;9 until recently, little is known about
clinical outcomes, especially long-term outcomes, among
patients who have CKD and experience superimposed AKI
(CKD–AKI).10 The high rate of non-recovered kidney
function among patients with CKD–AKI contrasts sharply
with observations made among patients without prior CKD.7
Non-recovery of renal function after AKI may be an
important contributor to growth in the number of incident
end-stage renal disease (ESRD) cases out of proportion to the
increase in the prevalence of CKD.11 The Acute Dialysis
or ig ina l a r t i c l e http://www.kidney-international.org
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Initiative Group introduced a classification system for AKI
(risk, injury, failure, loss, and end stage (RIFLE)) to provide a
standardized evaluation of AKI.12 Although the disease
course and long-term outcome are thought to be different
in AKI patients with or without prior CKD requiring dialysis,
no study has compared the rate of mortality or long-term
dialysis between CKD–AKI and non-CKD–non-AKI patients
within the same cohort.13 The current study was designed to
determine the outcomes among patients grouped by different
CKD and AKI status. We hypothesized that hospital survival
patients with CKD–AKI have higher risks for long-term
mortality and dialysis dependence than AKI patients without
a prior CKD. The long-term outcomes by different levels of
AKI, as defined by RIFLE criteria in the non-CKD population
and by different levels of recovery of renal function in
hospital survivors, were also reported.
RESULTS
Demographic characteristics of patients
Among 10,804 enrolled patients (mean age, 59.9±16.8
years), 1379 patients died during hospital admission. A total
of 9425 patients survived to hospital discharge and were
included for analysis (Figure 1). The Charlson score was
3.5±4.7 and Acute Physiology and Chronic Health Evalua-
tion II (APACHE II) score at intensive care unit (ICU)
admission was 10.3±6.6. A total of 351 patients (3.7%)
presented with documented CKD, and 192 patients (2%) had
ESRD before major surgery. Among the patients who
survived to discharge after the index admission, 4393 patients
(46.6%) had an episode of AKI during the hospitalization
and were categorized as follows: 2434 (25.8%) had ‘simpli-
fied’ RIFLE (sRIFLE)-R, 979 (10.4%) had sRIFLE-I, 745
(7.9%) had sRIFLE-F, and 235 (2.5%) had CKD–AKI. The
baseline characteristics of the study population are shown in
Table 1.
Of the patients who survived to discharge with or without
prior CKD, 4724 (53.2%) and 116 (33.0%) had no AKI
during hospital admission, respectively. The kidney recovery
rate was higher in AKI patients without CKD than those with
CKD (86.7 vs. 72.3%; Po0.01). Among patients surviving
after the index admission, only 182 patients (2.0%) required
long-term dialysis. The rate of patients requiring dialysis at
discharge was lower in patients without CKD than in patients
with CKD (1.0 vs. 25.6%; Po0.01).
Long-term all-cause mortality
After discharge with a median (interquartile range) follow-up
of 4.76 years (3.37–6.61 years), the incidences of all-cause
mortality were 5.9, 14.0, and 16.7 per 100 person-years
among patients without CKD, with CKD, and ESRD,
respectively. The Cox proportional hazard model showed
that ESRD patients had a significantly worse long-term
survival during the follow-up period, with an adjusted hazard
ratio (HR) of 4.59 and 95% confidence interval (CI) of
3.69–5.71 (Po0.001) with reference to patients without CKD
and AKI. Patients with CKD–AKI had a similarly poor
outcome (HR, 2.62; 95% CI, 1.92–3.57; Po0.001; Table 2).
Furthermore, the HRs for death elevated with the increased
severity of AKI in patients without prior CKD (HRs, 1.62 in
sRIFLE-R, 2.41 in sRIFLE-I, and 3.06 in sRIFLE-F; all
Po0.001; Table 2 and Figure 2).
Other factors significantly related to long-term mortality
were older age (HR, 1.03; 95% CI, 1.02–1.03), male gender
(HR, 1.36; 95% CI, 1.25–1.48), tracheostomy (HR, 1.77; 95%
CI, 1.53–2.05), cardiopulmonary resuscitation (HR, 1.57;
95% CI, 1.16–2.11), congestive heart failure (HR, 1.43; 95%
CI, 1.25–1.64), and coronary artery disease (HR, 1.61; 95%
CI, 1.44–1.79).
Furthermore, we performed the outcome analysis by the
kidney recovery at the index discharge. As compared with
patients without CKD and AKI, those with CKD–AKI
without renal function recovery had the highest mortality
(HR, 4.59; 95% CI, 3.20–6.45), followed by patients with
ESRD (HR, 4.40; 95% CI, 3.54–5.48), CKD with recovery
(HR, 3.00; 95% CI, 2.35–3.84), CKD–non-AKI (HR, 2.59;
95% CI, 1.90–3.53), non-CKD without recovery (HR, 2.18;
95% CI, 1.24–3.84), and non-CKD with recovery (HR, 1.96;
95% CI, 1.78–2.16; all Po0.001; Figure 3).
In the sensitivity analysis, similar results were noted when
we analyzed patients who underwent cardiovascular surgery.
After discharge, 486 (17.0%) patients died. ESRD patients
had the highest risk of long-term mortality (HR, 6.37; 95%
CI, 4.51–9.02, Po0.001), and CKD–AKI patients had a
Patients admitted to surgical ICU after major surgery during 2002–2008
(n =17,788)
Patients excluded for
ICU stay 2 days (n =6305)
Patients retrieved for detailed evaluation
(n =11,483)
Patients enrolled (n =10,804)
Death during index admission
(n =1379)
Patients survived to hospital discharge
(n=9425)
Without prior CKD
(n=8882)
No AKI (n =4724)
RIFLE–R (n =2434)
RIFLE–I (n =979)
RIFLE–F (n =745)
No AKI (n =116)
AKI (n=235)
With prior CKD
(n=351)
ESRD
(n=192)
Patients excluded for
A. Kidney transplant (n=50)
B. Repeated admission (n=629)
Figure 1 | Flow diagram of the study population. AKI, acute
kidney injury; CKD, chronic kidney disease; ESRD, end-stage renal
disease; ICU, intensive care unit; RIFLE, risk, injury, failure, loss, and
end stage.
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similar risk of long-term mortality (HR, 3.94; 95% CI,
2.79–5.28; Po0.001), as compared with patients without
CKD and AKI as a reference. When compared with patients
without CKD and AKI, AKI patients without prior CKD had
HRs of 1.35, 2.38, and 3.28 in sRIFLE-R, -I, and -F
classification, respectively. After discharge, 87 (3%) CKD–
AKI patients died and had the highest HR (60.02; 95% CI,
26.94–133.72; Po0.001) for long-term dialysis. By includingTa
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Figure 2 | Long-term survival stratified by CKD and AKI. Cox
proportional hazard model for long-term survival of patients alive
at hospital discharge, stratified by severity of AKI for non-CKD
patients and by occurrence of AKI for CKD patients (non-CKD
patients were categorized into non-AKI, risk, injury, and failure
groups; CKD patients were categorized into non-AKI and AKI
groups, all Po0.001, non-CKD–non-AKI was the reference). AKI,
acute kidney injury; CKD, chronic kidney disease; CKD–AKI, acute-
on-chronic kidney disease; ESRD, end-stage renal disease.
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Figure 3 | Long-term survival stratified by kidney recovery.
Cox proportional hazard model for long-term survival of patients
alive at hospital discharge, stratified by the status of kidney
recovery. AKI, acute kidney injury; CKD, chronic kidney disease;
ESRD, end-stage renal disease; R, recovery; non-R, non-recovery;
Non-CKD–non-AKI was the reference; all Po0.001.
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patients without CKD and AKI as a reference among
cardiovascular surgery patients, AKI patients without prior
CKD had HRs of 1.78 (P¼ 0.270), 4.01 (P¼ 0.017), and
15.64 (Po0.001) in sRIFLE-R, -I, and -F, respectively.
Long-term dialysis
Although 40 non-CKD AKI patients (0.96%) required
dialysis at the time of discharge, only a small proportion of
discharged patients without prior CKD (n¼ 92, 1.0%)
progressed to ESRD in the follow-up period; however, 90
CKD patients (25.6%) progressed to ESRD. After a median
(interquartile range) follow-up of 4.62 years, the total
incidence rate of ESRD was 17.8 and 0.15 per 100 person-
years among hospital survival patients with and without
prior CKD, respectively. Patients with CKD–AKI had the
highest risk for long-term dialysis (HR, 122.9; 95% CI,
66.8–253.9; Po0.001;), followed by patients with CKD and
non-AKI (HR, 52.0; 95% CI, 25.6–105.8; Po0.001; Table 2
and Figure 4). Furthermore, the HRs for long-term dialysis
elevated with the increased severity of AKI in patients
without prior CKD (HRs, 2.09 in sRIFLE-R, 3.19 in sRIFLE-I,
and 22.35 in sRIFLE-F; all Po0.001, compared with patients
without CKD and AKI).
After index discharge, CKD patients without kidney
recovery at the time of discharge had the worst risk of
long-term dialysis (HR, 212.73; 95% CI, 105.53–428.83),
followed by CKD patients with recovery (HR, 74.07; 95% CI,
38.82–141.32), non-CKD without recovery (HR, 60.95; 95%
CI, 24.13–153.97), CKD–non AKI (HR, 42.63; 95% CI,
20.82–87.29), and non-CKD with recovery (HR, 4.50; 95%
CI, 2.43–8.35) compared with patients with non-CKD–non-
AKI (reference group; all Po0.001, Figure 5).
Long-term outcomes stratified by CKD and AKI status
Table 3 showed the HR of each risk group stratified by CKD
and AKI status, and the HRs are compared with a different
reference. The AKI patients who had prior CKD were at
higher risk for long-term dialysis and mortality after major
surgery than those without prior CKD. Moreover, the AKI
itself confers a risk for long-term dialysis and mortality no
matter in CKD or without prior CKD patients.
DISCUSSION
We used the most standard definition with a full spectrum of
severity for AKI and CKD, which provided a better-defined
comparison of a more homogeneous population.5 Relatively
little attention has been paid to the relationship between
prior CKD, especially CKD–AKI, and the risk of long-term
dialysis and mortality in postoperative patients.
Long-term mortality among CKD–AKI patients
Our long-term results do not concur with two previous
studies that showed lower mortality rate associated with AKI
in prior CKD patients, both at ICU discharge and at 90 days
in the critical setting.8,14 Khosla et al.8 reported that
CKD–AKI is associated with less short-term mortality than
de novo AKI because of earlier nephrology consultation.
However, in the long-term follow-up, CKD–AKI had the
worst prognosis among AKI and is comparable to ESRD
patients after adjustment for perioperative confounding
factors. These comorbidities per se may lead to more frequent
exposure to nephrotoxis insults and/or alter the response to
an acute insult.15 It was supposed that the postoperative
complications induce a cascade of inflammatory processes
that ultimately influence survival beyond hospital dis-
charge.16 Alterations to the metabolic and hormonal milieu
of the CKD, including reduced nitric oxide activity, increased
levels of angiotensin II and so on, could increase the
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Figure 4 | Long-term dialysis dependence stratified by CKD
and AKI. Proportion of freedom from dialysis dependence of
patients alive at hospital discharge, stratified by severity of AKI for
non-CKD patients and by occurrence of AKI for CKD patients. AKI,
acute kidney injury; CKD, chronic kidney disease; CKD–AKI, acute-
on-chronic kidney disease; risk, P¼ 0.056; injury, P¼ 0.017; all
others Po0.001. Non-CKD–non-AKI was the reference.
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Figure 5 | Long-term dialysis dependence stratified by kidney
recovery. Proportion of freedom from dialysis dependence of
patients alive at hospital discharge, stratified by the status of
kidney recovery. AKI, acute kidney injury; CKD, chronic kidney
disease; non-R, non-recovery; R, recovery; all Po0.001. Non-
CKD–non-AKI was the reference.
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susceptibility to injury in AKI.15 The existing literature
reports preoperative CKD as a recognized risk factor for in-
hospital and postdischarge morality.17,18 We further found
that CKD is associated with long-term adverse outcomes in
postsurgical AKI patients, although this does not imply
causality. Patients with CKD are often sicker than those
without prior CKD. In this multivariate analysis, the strength
of association between CKD and mortality was greater than
that associated with other established risk factors, including
congestive heart failure, coronary artery disease, and
perioperative management in critical settings.
Several studies have shown that underlying CKD markedly
increases the risk of AKI, and the risk increases in proportion
to the CKD stage.19,20 Our results further showed that
CKD–AKI patients had a worse survival than AKI patients
without CKD at all time points up to 4 years following
surgery. As CKD is a well-recognized risk factor for
cardiovascular morbidity and mortality,6 more aggressive
close follow-up in AKI patients with prior CKD may be
warranted.
Long-term dialysis among acute-on-chronic kidney injury
patients
CKD patients without AKI still had a higher risk than non-
CKD patients with AKI of long-term dialysis after major
surgery. When risk factors for AKI are assessed, preoperative
baseline CKD was shown to be a significant and consistent
risk for the development of AKI.21,22 A baseline CKD is also a
strong risk factor for more severe CKD, including ESRD.23
Although some non-CKD–AKI patients required dialysis,
only a small proportion of discharged patients may progress
to ESRD, and most patients had a full restoration of renal
function;21,24 however, in postoperative critical patients with
prior CKD, greater than one-fourth of patients progressed to
ESRD. Our long-term result enforced the recent report that
AKI superimposed on CKD leads to ESRD at a higher
incidence than doses of AKI alone.20,21
Most studies have suggested that patients with prior CKD
are more likely to remain dialysis dependent after an episode
of AKI requiring dialysis.25,26 CKD has been identified as a
risk factor for AKI after multivariate adjustment for
comorbidities of radiocontrast administration, sepsis, and
cardiac surgery.27 Various adaptations in physiology of CKD
can alter the response to AKI.15 This would emphasize the
importance of nephrology follow-up in CKD–AKI survivors.
CKD itself may require specialized care for rigorous
avoidance of potentially nephrotoxic drug or metabolic
factors after discharge, which may hasten progression to
ESRD.
Kidney recovery and long-term outcomes
Postoperative temporary worsening of kidney function is
associated with higher long-term mortality.28 It was postu-
lated that CKD after discharge is one of the potential
mechanisms that exposed these patients to increased
cardiovascular morbidity and mortality.29 In our study,T
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CKD patients without kidney recovery after AKI had the
greatest risk for death compared with other patients,
including ESRD. Furthermore, we found that CKD patients
even with kidney recovery from AKI still had a high risk for
long-term dialysis compared with non-CKD–AKI patients
with non-recovery. This risk was independent of other
perioperative comorbidities, complications, and procedures.
(Figure 5).
Earlier identification of CKD–AKI
CKD–AKI should no longer simply be viewed by its overall
severity of illness, but rather CKD itself can exhibit important
adverse effects on outcome and may extend well beyond the
hospital period. This result suggests an expected poor
outcome for postsurgical AKI patients with prior CKD with
regard to long-term dialysis and mortality.
Earlier identification of AKI among patients with prior
CKD could have modified the process of care delivered to
these patients. On the contrary, prior CKD should demand
more concern for kidney function monitor. This is an
important insight for physicians who take care of post-
operative patients, and determine the optimal postdischarge
follow-up of kidney function for CKD patients even with
recovery at the time of discharge. Taken together, it is
reasonable to make efforts to find a prior history of CKD
before operation. Different strategies may apply to AKI
patients with and without prior CKD because of its different
effects on long-term mortality and dialysis dependence,
especially in postoperative patients.
Study limitations
There are some important limitations to our analysis. There
is a lack of linkage between individual patients and their AKI
etiologies; however, most severe postoperative AKIs are due
to acute tubular necrosis. No conclusive data exist to
demonstrate that the traditional etiological categories of
AKI have meaningful prognostic differences.10 As an
observational study, results could be influenced by residual
confounding factors for which we could not adjust.
Heterogeneous definitions of AKI are an important issue in
research pertaining to AKI. Most of our patients received
cardiovascular surgery (30.4%); however, in our sensitivity
analysis, trends to long-term mortality and dialysis depen-
dence remained the same. Therefore, it is unlikely that
difference in outcome risk was solely due to surgical
categories. The designation of CKD was multidimensional,
and we could not define the duration of CKD. However, the
risks of mortality and long-term dialysis associated with
serum creatinine (sCr) change were constant over time.
In conclusion, in a large cohort of AKI patients after
major surgery, those with prior CKD were at a higher risk for
long-term mortality and dialysis dependence after hospital
discharge than those without CKD. The HRs of long-term
mortality were in a disease severity-response manner,
classified by sRIFLE criteria in those patients without prior
CKD. For CKD patients with kidney recovery from AKI at
discharge, the risk for death or long-term dialysis was higher
compared with patients without CKD. Further study is
necessary to devise strategies to retard the development of
kidney failure for optimal follow-up for CKD–AKI patients
after discharge in clinical practice.
PATIENTS AND METHODS
Study cohort
This study was an observational study of prospectively
collected data based on the database of the National Taiwan
University Hospital Study Group on Acute Renal Failure. The
database was constructed prospectively for outcome assur-
ance between January 2002 and January 2008 in one medical
center (National Taiwan University Hospital in Taipei,
Taiwan) and its three branch hospitals in different cities.30–34
Data related to individual identification were removed and
the patients remained anonymous during the entire study.
The study was approved by the Institutional Review Board of
the National Taiwan University Hospital (no. 31MD03).
Informed consent was waived because there was no breach of
privacy and the study did not interfere with clinical decisions
related to patient care.
There were 17,788 admissions to the ICU after major
surgery during the study period. Surgical procedures were
considered major if the length of stay for patients in a given
diagnosis-related group exceeded 2 days.35 Patients were
excluded if they stayed in the ICU for p2 days (n¼ 6305).
Repeated ICU admission after the index discharge was
excluded (n¼ 629). Kidney transplant recipients were
excluded as well (n¼ 50). To determine the long-term
outcomes,5 we also excluded patients who died during
hospital admission (n¼ 1379).
Clinical assessment of study patients
Demographics and baseline clinical characteristics were
assessed at the time of hospital admission. Clinical evalua-
tions included medical history, physical examination, and
identification of comorbid diseases. Pertinent medical history
included hypertension (defined as taking antihypertensive
drugs, or systolic and diastolic blood pressures 4145/
95 mm Hg at the time of hospitalization), diabetes mellitus
(defined as being treated with oral hypoglycemic agents or
insulin), cirrhosis (defined by image studies with computed
tomography or sonagraphy), congestive heart failure (defined
as New York Heart Association functional class III or IV),
chronic obstructive pulmonary disease (defined as requiring
long-term bronchodilators or steroids), and coronary
artery disease (defined by the diagnosis of ischemic heart
disease before admission and positive electrocardiographic
findings). Sepsis was defined as at least two signs of
systemic inflammatory response syndrome with clinical
evidence of infection.36 Acute decompensated hepatic failure
was defined for cases in which encephalopathy occurred
within 7 days of the onset of jaundice.32 Patients with
associated diseases were assessed using the Charlson comor-
bidity score.37
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The eGFR was obtained by using the Chinese Modification
of Diet in Renal Disease Study equation (GFR¼
175 (sCr)1.234 age0.179 (0.79, if women)). The eGFR
values were proportioned to 1.73 m2 of the body surface
area.38 CKD was defined according to an eGFR p45 ml/min
per 1.73 m2 (ref. 7). AKI was classified according to the RIFLE
criteria, which was introduced by the Acute Dialysis Initiative
Group as a standardized evaluation tool.12 Similar to
previous studies,34,39–41 we used the sRIFLE classification in
which only creatinine was used for classification. AKI was
stratified according to the maximum sRIFLE classification
during the hospital admission.5 The baseline sCr was the
nadir value obtained from the previous admission in those
who had more than one admission within 1 year before the
index admission,39 or the nadir sCr value during the
admission after emergency department measurement.6,42
CKD–AKI was defined as patients with a baseline eGFR
p45 ml/min per 1.73 m2 who had acute elevation of sCr
450% ( 1.5) or a decrease of eGFR425% (more than the
‘risk’ of RIFLE). A baseline sCrX4.0 mg/dl with an acute rise
of at least 0.5 mg/dl13 was defined as ‘failure.’
Recovery of renal function
Kidney recovery existed if the discharge sCr remainedo50%
above baseline sCr,6 whereas non-recovery existed if there was
a persistent increase in sCr 450% above the baseline sCr or
need for dialysis at the time of hospital discharge.
Renal replacement therapy
The choice of renal replacement therapy modality was made
according to the evaluation of the attending physicians after
considering the clinical characteristics of the patients. The
indications for renal replacement therapy were the same as
described in previous reports32–34, namely azotemia, blood
urea nitrogen 480 mg/dl, and sCre 42 mg/dl with uremic
symptoms; fluid overload with a central venous pressure level
412 mm Hg or pulmonary edema with a PaO2/FiO2 o300;
hyperkalemia, serum Kþ 45.5 mmol/l despite medical
treatment; oliguria, urine output o100 ml/8 h with or
without the use of diuretics; and acidosis, pH o7.2 on
arterial blood gas analysis. Long-term dialysis was defined as
dialysis for at least 90 days.43
Outcome measurement
Patient survival after discharge was determined through the
databank of the National Health Insurance Research Database
in January 2009.44 The National Health Insurance Research
Database contains health-care data from499% of the entire
population in Taiwan (23.74 million), and covers all inpatient
and outpatient medical benefit claims. We also crosslinked
our study population with the nationally comprehensive
Taiwan Society Nephrology registry, which receives the data
reports of all dialysis patients every 3 months. The long-term
all-cause mortality was the primary end point of the study.
The secondary end point was the event of long-term dialysis
dependence. The long-term outcomes in different stages of
AKI classified by sRIFLE criteria in the non-CKD population
and in different levels of renal function recovery of inhospital
survivors were also reported.
Role of the funding source
There were no conflicts from funding source for this study.
The corresponding authors had full access to all the data in
the study and had final responsibility for the decision to
submit the findings for publication.
Statistical analysis
Statistical analyses were performed with SPSS for Windows
(version 15.0; SPSS, Chicago, IL). A two-sided P-valuep0.05
was considered statistically significant. The continuous
variables were summarized as mean±s.d. unless otherwise
specified, whereas the categorical variables were presented as
number (percentage). Two-sample Student’s t-test was used
to analyze continuous data and w2-test or Fisher’s exact test
was used to analyze categorical data.
The long-term survival rates use Cox proportional hazard
model adjusted for age, gender, admission subgroups,
intervention (ECMO, Intra-aortic balloon pump, ventilator,
intracranial pressure, Swan–Ganz tube, PiCCO, Sengstaken–-
Blakemore tube, and transcutaneous pacemaker, comorbidity
(hypertension, liver cirrhosis, congestive heart failure,
diabetes mellitus, chronic obstructive pulmonary disease,
coronary artery disease, hepatitis, cancer, and atrial fibrilla-
tion), admission subgroups, Charlson score) and censored on
1 January 2009. Age and Charlson score were modeled as
continuous variables. Survival curves for all-cause mortality
or freedom from dialysis were generated from adjusted Cox
models. For long-term dialysis, an individual who survived at
index discharge was censored at death or at the end of the
study period. Crude HRs and 95% CIs were derived from a
Cox proportional hazard model. Incidence rates of chronic
dialysis and all-cause mortality were determined for partici-
pants with and without AKI. The proportionality assumption
of the Cox models was confirmed with Schoenfeld residual
plots.
Sensitivity analysis was undertaken among the subset of
patients undergoing cardiovascular surgery because it
represented a large proportion of our study population.
The authors had full access to and take full responsibility
for the integrity of the data. All authors have read and agreed
with the manuscript as written.
DISCLOSURE
All the authors declared no competing interests.
ACKNOWLEDGMENTS
We thank the staff of the Second and Eighth Core Lab of the
Department of Medical Research in National Taiwan University
Hospital for technical assistance. We express our sincere gratitude
to all participants of the National Taiwan University Hospital Study
Group on Acute Renal Failure. This study was supported by The
Ta-Tung Kidney Foundation and Taiwan National Science Council (grant
NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-
B-002-155-MY2, NSC 98-2314-B-002-155-MY4, and NTUH.098-001177,
NTUH 100-001667).
Kidney International (2011) 80, 1222–1230 1229
V-C Wu et al.: Acute-on-chronic kidney disease and long-term mortality o r ig ina l a r t i c l e
REFERENCES
1. Reddy VG. Prevention of postoperative acute renal failure. J Postgrad Med
2002; 48: 64–70.
2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on
mortality. A cohort analysis. JAMA 1996; 275: 1489–1494.
3. Mangano CM, Diamondstone LS, Ramsay JG et al. Renal dysfunction after
myocardial revascularization: risk factors, adverse outcomes, and hospital
resource utilization. The Multicenter Study of Perioperative Ischemia
Research Group. Ann Intern Med 1998; 128: 194–203.
4. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum
creatinine predict prognosis in patients after cardiothoracic surgery: a
prospective cohort study. J Am Soc Nephrol 2004; 15: 1597–1605.
5. Bihorac A, Yavas S, Subbiah S et al. Long-term risk of mortality and acute
kidney injury during hospitalization after major surgery. Ann Surg 2009;
249: 851–858.
6. Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with
increased long-term mortality after cardiothoracic surgery. Circulation
2009; 119: 2444–2453.
7. Hsu CY, Chertow GM, McCulloch CE et al. Nonrecovery of kidney function
and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009;
4: 891–898.
8. Khosla N, Soroko SB, Chertow GM et al. Preexisting chronic kidney
disease: a potential for improved outcomes from acute kidney injury. Clin
J Am Soc Nephrol 2009; 4: 1914–1919.
9. Browner WS, Li J, Mangano DT. In-hospital and long-term mortality in
male veterans following noncardiac surgery. The Study of Perioperative
Ischemia Research Group. JAMA 1992; 268: 228–232.
10. Kellum JA. Prerenal azotemia: still a useful concept? Crit Care Med 2007;
35: 1630–1631.
11. Lin CL, Pan KY, Hsu PY et al. Preoperative 24-h urine amount as an
independent predictor of renal outcome in poor cardiac function patients
after coronary artery bypass grafting. J Crit Care 2004; 19: 92–98.
12. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure—definition,
outcome measures, animal models, fluid therapy and information
technology needs: the Second International Consensus Conference of the
Acute Dialysis Quality Initiative (ADQI) Group. Crit care (London, England)
2004; 8: R204–R212.
13. Coca SG, Yusuf B, Shlipak MG et al. Long-term risk of mortality and other
adverse outcomes after acute kidney injury: a systematic review and
meta-analysis. Am J Kidney Dis 2009; 53: 961–973.
14. Groeneveld AB, Tran DD, van der Meulen J et al. Acute renal failure in the
medical intensive care unit: predisposing, complicating factors and
outcome. Nephron 1991; 59: 602–610.
15. Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: an inherent
risk factor for acute kidney injury? Clin J Am Soc Nephrol 2010; 5:
1690–1695.
16. Khuri SF, Henderson WG, DePalma RG et al. Determinants of long-term
survival after major surgery and the adverse effect of postoperative
complications. Ann Surg 2005; 242: 326–341; discussion 341–343.
17. Thakar CV, Worley S, Arrigain S et al. Influence of renal dysfunction on
mortality after cardiac surgery: modifying effect of preoperative renal
function. Kidney Int 2005; 67: 1112–1119.
18. Arnaoutakis GJ, Bihorac A, Martin TD et al. RIFLE criteria for acute kidney
injury in aortic arch surgery. J Thoracic Cardiovasc Surg 2007; 134:
1554–1560; discussion 1560–1561.
19. Hsu CY, Ordonez JD, Chertow GM et al. The risk of acute renal
failure in patients with chronic kidney disease. Kidney Int 2008; 74:
101–107.
20. Ishani A, Xue JL, Himmelfarb J et al. Acute kidney injury increases risk of
ESRD among elderly. J Am Soc Nephrol 2009; 20: 223–228.
21. Amdur RL, Chawla LS, Amodeo S et al. Outcomes following diagnosis of
acute renal failure in US veterans: focus on acute tubular necrosis. Kidney
Int 2009; 76: 1089–1097.
22. Hoste EA, Lameire NH, Vanholder RC et al. Acute renal failure in patients
with sepsis in a surgical ICU: predictive factors, incidence, comorbidity,
and outcome. J Am Soc Nephrol 2003; 14: 1022–1030.
23. Newsome BB, Warnock DG, McClellan WM et al. Long-term risk of
mortality and end-stage renal disease among the elderly after small
increases in serum creatinine level during hospitalization for acute
myocardial infarction. Arch Intern Med 2008; 168: 609–616.
24. Liano F, Felipe C, Tenorio MT et al. Long-term outcome of acute
tubular necrosis: a contribution to its natural history. Kidney Int 2007; 71:
679–686.
25. Bagshaw SM, Laupland KB, Doig CJ et al. Prognosis for long-term survival
and renal recovery in critically ill patients with severe acute renal failure: a
population-based study. Crit care (London, England) 2005; 9: R700–R709.
26. Prescott GJ, Metcalfe W, Baharani J et al. A prospective national study of
acute renal failure treated with RRT: incidence, aetiology and outcomes.
Nephrol Dial Transplant 2007; 22: 2513–2519.
27. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes
of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 844–861.
28. Welten GM, Schouten O, Chonchol M et al. Temporary worsening of renal
function after aortic surgery is associated with higher long-term
mortality. Am J Kidney Dis 2007; 50: 219–228.
29. Manjunath G, Tighiouart H, Ibrahim H et al. Level of kidney function as a
risk factor for atherosclerotic cardiovascular outcomes in the community.
J Am Coll Cardiol 2003; 41: 47–55.
30. Huang TM, Wu VC, Young GH et al. Preoperative proteinuria predicts
adverse renal outcomes after coronary artery bypass grafting. J Am Soc
Nephrol 2011; 22: 156–163.
31. Wu VC, Wang CH, Wang WJ et al. Sustained low-efficiency dialysis versus
continuous veno-venous hemofiltration for postsurgical acute renal
failure. Am J Surg 2009; 199: 466–476.
32. Wu VC, Ko WJ, Chang HW et al. Early renal replacement therapy in
patients with postoperative acute liver failure associated with acute renal
failure: effect on postoperative outcomes. J Am Coll Surg 2007; 205:
266–276.
33. Wu VC, Ko WJ, Chang HW et al. Risk factors of early redialysis after
weaning from postoperative acute renal replacement therapy. Intensive
Care Med 2008; 34: 101–108.
34. Shiao CC, Wu VC, Li WY et al. Late initiation of renal replacement therapy
is associated with worse outcomes in acute kidney injury after major
abdominal surgery. Crit Care (London, England) 2009; 13: R171.
35. Lindenauer PK, Pekow P, Wang K et al. Perioperative beta-blocker therapy
and mortality after major noncardiac surgery. N Engl J Med 2005; 353:
349–361.
36. Bone RC. Immunologic dissonance: a continuing evolution in our
understanding of the systemic inflammatory response syndrome (SIRS)
and the multiple organ dysfunction syndrome (MODS). Ann Intern Med
1996; 125: 680–687.
37. Charlson ME, Pompei P, Ales KL et al. A new method of classifying
prognostic comorbidity in longitudinal studies: development and
validation. J Chronic Dis 1987; 40: 373–383.
38. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating
equation for Chinese patients with chronic kidney disease. J Am Soc
Nephrol 2006; 17: 2937–2944.
39. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE
criteria for acute renal failure in hospitalized patients. Crit Care Med 2006;
34: 1913–1917.
40. Ostermann M, Chang R. Correlation between the AKI classification and
outcome. Crit Care 2008; 12: R144.
41. Li WX, Chen HD, Wang XW et al. Predictive value of RIFLE classification on
prognosis of critically ill patients with acute kidney injury treated with
continuous renal replacement therapy. Chin Med J (Engl) 2009; 122:
1020–1025.
42. Palevsky PM, Zhang JH, O’Connor TZ et al. Intensity of renal support in
critically ill patients with acute kidney injury. N Engl J Med 2008; 359:
7–20.
43. Wald R, Quinn RR, Luo J et al. Chronic dialysis and death among survivors
of acute kidney injury requiring dialysis. JAMA 2009; 302: 1179–1185.
44. Insurance BoNH. National Health Insurance in Taiwan. Available at
www.nhi.gov.tw/english, 2007; accessed 20 August 2009.
1230 Kidney International (2011) 80, 1222–1230
or ig ina l a r t i c l e V-C Wu et al.: Acute-on-chronic kidney disease and long-term mortality
